About GEN Protocols

Published by Genetic Engineering & Biotechnology News (GEN), GEN Protocols is the dynamic hub for editorially curated, freely accessible scientific protocols, protocol preprints, software tools, applications, technical tutorials, and tips & tricks in biotechnology. GEN Protocols aims to foster reproducibility, transparency, and collaboration across biotechnology research through a user-friendly, up-to-date, and interactive web resource.

GEN Protocols is curated by the renowned editors of GEN and organized into the core areas of Drug Discovery, Cancer, OMICs, COVID, Genome Editing, Translational Medicine, Analytical Testing, and Computational Biosciences. All protocols are published open access to encourage broad discoverability, sharing, and networking across academia and industry.

Complementing the online hub is the annual GEN Protocols Guide, published in print and digital and delivering insightful editorial coverage of the technical trends in the eight core areas of biotechnology.

The GEN Protocols Team

Anjali A. Sarkar, PhD

Anjali A. Sarkar, PhD
Science Editor
Genetic Engineering & Biotechnology News (GEN)

Bill Levine

Bill Levine
VP, Commercial Director
Genetic Engineering & Biotechnology News (GEN)

Sande Giaccone

Sande Giaccone
Publisher
Genetic Engineering & Biotechnology News (GEN)

About Genetic Engineering & Biotechnology News (GEN)

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success.